Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 52Leukemia, Myeloid, Acute 51Myelodysplastic Syndromes 45Leukemia 34Lymphoma, Non-Hodgkin 33Lymphoma 28Leukemia, Myelogenous, Chronic, BCR-ABL Positive 24Hematologic Neoplasms 20Breast Neoplasms 19Hodgkin Disease 18Leukemia, Lymphocytic, Chronic, B-Cell 16Burkitt Lymphoma 15Multiple Myeloma 13Neuroblastoma 12Lymphoma, Large B-Cell, Diffuse 12Leukemia, Myeloid, Accelerated Phase 12Leukemia, Biphenotypic, Acute 11Central Nervous System Neoplasms 11Blast Crisis 11Lymphoma, Large-Cell, Immunoblastic 10Lymphoma, Follicular 10Graft vs Host Disease 10Dendritic Cell Sarcoma, Interdigitating 10Anemia, Refractory, with Excess of Blasts 10Recurrence 9Myeloproliferative Disorders 9Medulloblastoma 9Lymphoma, Mantle-Cell 9Leukemia, Myeloid, Chronic-Phase 9Congenital Abnormalities 9

Interventions

Blood Specimen Collection 25Reverse Transcriptase Polymerase Chain Reaction 7Flow Cytometry 7Liquid Biopsy 4cabazitaxel 3Surgical Procedures, Operative 3Propofol 3Carboplatin 3Bevacizumab 3Trastuzumab 2Spinal Puncture 2Sevoflurane 2Positron Emission Tomography Computed Tomography 2Pirinitramide 2Neoadjuvant Therapy 2Morphine 2Laparoscopy 2Hematologic Tests 2Folfox protocol 2Epirubicin 2Drug Therapy 2Docetaxel 2Cyclophosphamide 2Cisplatin 2Cetuximab 2Capecitabine 2Aspirin 2Anesthesia, General 2ribociclib 1pertuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoplastic Cells, Circulating × Thiotepa × Clear all
NCT00429182 2013-04-10

Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
32 enrolled 6 charts
Breast

Breast Neoplasms, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡